[1]杨晓悦,李毓龙,罗仲秋,等.结合分枝杆菌感染者辅助性Th2型细胞因子IL-4、IL-6、IL-10的水平变化[J].医学信息,2023,36(01):113-116.[doi:10.3969/j.issn.1006-1959.2023.01.022]
　YANG Xiao-yue,LI Yu-long,LUO Zhong-qiu,et al.Changes of Helper Th2 Cytokines IL-4, IL-6 and IL-10 Levels in Patients with Mycobacterium Tuberculosis Infection[J].Journal of Medical Information,2023,36(01):113-116.[doi:10.3969/j.issn.1006-1959.2023.01.022]
点击复制

结合分枝杆菌感染者辅助性Th2型细胞因子IL-4、IL-6、IL-10的水平变化()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年01期
页码:
113-116
栏目:
论著
出版日期:
2023-01-01

文章信息/Info

Title:
Changes of Helper Th2 Cytokines IL-4, IL-6 and IL-10 Levels in Patients with Mycobacterium Tuberculosis Infection
文章编号:
1006-1959（2023）01-0113-04
作者:
杨晓悦; 李毓龙; 罗仲秋; 等
（简阳市人民医院实验医学科，四川 简阳 641400）
Author(s):
YANG Xiao-yue; LI Yu-long; LUO Zhong-qiu; et al.
(Department of Laboratory Medicine,the People’s Hospital of Jianyang City,Jianyang 641400,Sichuan,China)
关键词:
肺结核; 结核分枝杆菌; 白细胞介素4; 白细胞介素6; 白细胞介素10
Keywords:
Pulmonary tuberculosis; Mycobacterium tuberculosis; Interleukin-4; Interleukin-6; Interleukin-10
分类号:
R52
DOI:
10.3969/j.issn.1006-1959.2023.01.022
文献标志码:
A
摘要:
目的 通过检测结核患者、隐性结核杆菌感染者及健康人群的Th2型细胞因子白细胞介素4（IL-4）、白细胞介素6（IL-6）、白细胞介素10（IL-10）的变化，筛选潜伏性感染者，以进行早期治疗和防护。方法 选择简阳市人民医院2020年2月-2021年2月已确诊的活动性肺结核患者、潜伏性感染者及健康对照者各30例，分别作为活动性结核患者组（ATB组）、结核潜伏感染者组（LTBI组）、对照组，均进行结核感染T细胞检测，使用液相悬浮芯片技术测定血清中IL-4、IL-6、IL-10水平，比较三组IL-4、IL-6、IL-10水平。结果 ATB组、LTBI组、对照组IL-4水平依次增高，其中ATB组IL-4水平低于LTBI组和对照组，且LTBI组IL-4水平低于对照组，差异均有统计学意义（P＜0.05）；TB组、LTBI组、对照组IL-6水平依次降低，其中ATB组IL-6水平高于LTBI组，但差异无统计学意义（P＞0.05）；ATB组和LTBI组IL-6水平均高于对照组，差异有统计学意义（P＜0.05）；ATB组、LTBI组、对照组IL-10水平依次增高，其中ATB组IL-10水平低于LTBI组和对照组，差异有统计学意义（P＜0.05）；LTBI组IL-10水平低于对照组，但差异无统计学意义（P＞0.05）。结论 Th2型细胞因子IL-4、IL-10的水平变化可以区分活动性肺结核与潜伏性肺结核，临床可通过监测其水平对潜伏性结核感染者进行早期干预和治疗。
Abstract:
Objective To study the changes of Th2 cytokines interleukin-4 (IL-4), interleukin-6 (IL-6) and interleukin-10 (IL-10) in patients with tuberculosis, latent tuberculosis infection and healthy people, and to screen latent infection for early treatment and protection.Methods From February 2020 to February 2021, 30 patients with active pulmonary tuberculosis, 30 patients with latent tuberculosis infection and 30 healthy controls were selected from the People’s Hospital of Jianyang City as active tuberculosis group (ATB group), latent tuberculosis infection group (LTBI group) and control group, respectively. The T cells of tuberculosis infection were detected. The levels of IL-4, IL-6 and IL-10 in serum were measured by magnetic luminex screening assay. The levels of IL-4, IL-6 and IL-10 in the three groups were compared.Results The levels of IL-4 in ATB group, LTBI group and control group increased in turn, while the level of IL-4 in ATB group was lower than that in LTBI group and control group, and the level of IL-4 in LTBI group was lower than that in control group (P<0.05). The levels of IL-6 in TB group, LTBI group and control group decreased in turn, while the level of IL-6 in ATB group was higher than that in LTBI group, but the difference was not statistically significant (P>0.05); the levels of IL-6 in ATB group and LTBI group were higher than those in control group (P<0.05). The levels of IL-10 in ATB group, LTBI group and control group increased in turn, while the level of IL-10 in ATB group was lower than that in LTBI group and control group (P<0.05); the level of IL-10 in LTBI group was lower than that in control group, but the difference was not statistically significant (P>0.05).Conclusion The changes of Th2 cytokines IL-4 and IL-10 levels can distinguish active pulmonary tuberculosis from latent pulmonary tuberculosis. Early intervention and treatment of latent tuberculosis infection can be carried out by monitoring their levels.

参考文献/References:

[1]Li M,Chen T,Hua Z,et al.Global, regional, and national prevalence of diabetes mellitus in patients with pulmonary tuberculosis: a systematic review and meta-analysis[J].Diabetol Metab Syndr,2021,13(1):127.[2]Bekale RB,Du Plessis SM,Hsu NJ,et al.Mycobacterium tuberculosis and interactions with the host immune system:Opportunities for nanoparticle based immunotherapeutics and vaccines[J].Pharm Res,2018,36(1):8.[3]刘妲妲,董晓锋,梁栋.肺结核误诊为肺血管炎1例[J].甘肃医药,2021,40(11):1055-1056.[4]Wang YS,Zhu WL,Li T,et al.Changes in newly notified cases and control of tuberculosis in China: time-series analysis of surveillance data[J].Infect Dis Poverty,2021,10(1):16.[5]张玉萍,燕美琴,王丽萍,等.辅助性T细胞17和调节性T细胞相关细胞因子在不明原因复发性流产中的变化及意义[J].中国药物与临床,2019,19(8):1273-1275.[6]Rossouw M,Nel HJ,Cooke GS,et al.Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma gene[J].Lancet,2003,361(9372):1871-1872.[7]Stenger S,Hanson DA,Teitelbaum R,et al.An antimicrobial activity of cytolytic T cells mediated by granulysin[J].Science,1998,282(5386):121-125. [8]中华医学会结核病学分会.肺结核诊断和治疗指南[J].中华结合和呼吸杂志,2001,24(2):70-74.[9]Guo Z,Xiao D,Wang X,et al.Epidemiological characteristics of pulmonary tuberculosis in mainland China from 2004 to 2015:a model-based analysis[J].BMC Public Health,2019,19(1):219.[10]吴太锋,农峰,陈松强,等.广西骨关节结核患者血清中IL-4和IL-17水平的检测及临床意义[J].右江医学,2016,44(5):546-549.[11]武江海,舒敬奎,张剑青,等.结核与肿瘤患者胸腔积液中TNF-α,IFN-γ,IL-2,IL-4的水平及临床意义[J].昆明医科大学学报,2019,40(12):103-107.[12]Tekwu EM,Sidze LK,Assam JP,et al.Sequenceanalysis for detection of drug resistance in Mycobacteriumtuberculosis complex isolates from the central region of cameroon[J].BMC Microbiol,2014,14(1):113.[13]胡徳新,王敏,张丽娟,等.IFN-γ基因多态性与脊柱结核易感性及血清IL-4和IFN-γ的关系[J].中华医院感染学杂志,2020,30(4):568-571.[14]孙海柏,张丽霞.细胞因子检测在结核分枝杆菌感染中的研究进展[J].国际检验医学杂志,2018,39(4):465-468.[15]Verbon A,Juffermans NP,Deventer V,et al.Serum concentrations of cytokines in patients with active (TB) and after treatment[J].Clinical&Experimental Immunology,1999,115(1):110-113.[16]吕松琴,赵华,宝福凯,等.TNF-α和IFN-γ与T-SPOT.TB相结合应用于鉴别结核现症感染与隐性感染[J].昆明医科大学学报,2017,38(4):93-97.[17]Redford PS,Murray PJ,O’garra A.The role of IL-10 in immune regulation during M. tuberculosis infection[J].Mucosal Immunology,2011,4(3):261-270.[18]Cyktor JC,Carruthers B,Kominsky RA,et al.IL-10 inhibits mature fibrotic granuloma formation during Mycobacterium tuberculosis infection[J].Journal of Immunology,2013,190(6):2778-2790.[19]章敏.外周血 IFN-γ、IL-10 水平及红细胞免疫功能对重症肺结核患者死亡预后的预测价值[J]. 标记免疫分析与临床,2020,27(7):1161-1165.

相似文献/References:

[1]马 萌.健康咨询服务对肺结核知识知晓率的影响分析[J].医学信息,2018,31(06):160.[doi:10.3969/j.issn.1006-1959.2018.06.057]
　MA Meng.Analysis of the Influence of Health Counseling Service on Knowledge Awareness Rate of Pulmonary Tuberculosis[J].Journal of Medical Information,2018,31(01):160.[doi:10.3969/j.issn.1006-1959.2018.06.057]
[2]艾苗苗.肺结核的发病现状及有效预防控制策略分析[J].医学信息,2018,31(16):90.[doi:10.3969/j.issn.1006-1959.2018.16.026]
　AI Miao-miao.Analysis of the Current Situation of Tuberculosis and Effective Prevention and Control Strategy[J].Journal of Medical Information,2018,31(01):90.[doi:10.3969/j.issn.1006-1959.2018.16.026]
[3]李新刚.抗结核药物治疗所致肝损伤患者的危险因素及其治疗转归观察[J].医学信息,2019,32(03):155.[doi:10.3969/j.issn.1006-1959.2019.03.051]
　LI Xin-gang.Risk Factors and Treatment Outcomes of Patients with Liver Injury Caused by Anti-tuberculosis Drugs[J].Journal of Medical Information,2019,32(01):155.[doi:10.3969/j.issn.1006-1959.2019.03.051]
[4]陈 波,马晓波,洪国粦.Xpert MTB/RIF技术对结核分枝杆菌的诊断价值[J].医学信息,2019,32(06):172.[doi:10.3969/j.issn.1006-1959.2019.06.056]
　CHEN Bo,MA Xiao-bo,HONG Guo-lin.Diagnostic Value of Xpert MTB/RIF Technique for Mycobacterium Tuberculosis[J].Journal of Medical Information,2019,32(01):172.[doi:10.3969/j.issn.1006-1959.2019.06.056]
[5]胡立珍,周广信,霍丽丽,等.全自动半巢式实时荧光定量PCR技术检测 BALF诊断肺结核的价值[J].医学信息,2019,32(15):165.[doi:10.3969/j.issn.1006-1959.2019.15.056]
　HU Li-zhen,ZHOU Guang-xin,HUO Li-li,et al.Detection of the Value of BALF in the Diagnosis of Pulmonary Tuberculosis by Automatic Semi-nested Real-time PCR[J].Journal of Medical Information,2019,32(01):165.[doi:10.3969/j.issn.1006-1959.2019.15.056]
[6]刘 杰.静脉注射利福平治疗老年肺结核的疗效[J].医学信息,2019,32(18):142.[doi:10.3969/j.issn.1006-1959.2019.18.048]
　LIU Jie.Efficacy of Intravenous Rifampicin in the Treatment of Senile Pulmonary Tuberculosis[J].Journal of Medical Information,2019,32(01):142.[doi:10.3969/j.issn.1006-1959.2019.18.048]
[7]肖 勇,欧富华,况 杰.2013~2017年南昌市学生肺结核流行特征及防制措施[J].医学信息,2019,32(20):116.[doi:10.3969/j.issn.1006-1959.2019.20.035]
　XIAO Yong,OU Fu-hua,KUANG Jie.Epidemiological Characteristics and Control Measures of Tuberculosis among Students in Nanchang City from 2013 to 2017[J].Journal of Medical Information,2019,32(01):116.[doi:10.3969/j.issn.1006-1959.2019.20.035]
[8]李 鑫.肺结核合并气管支气管结核危险因素及诊断[J].医学信息,2020,33(01):32.[doi:10.3969/j.issn.1006-1959.2020.01.012]
　LI Xin.Risk Factors and Diagnosis of Tuberculosis with Tracheobronchial Tuberculosis[J].Journal of Medical Information,2020,33(01):32.[doi:10.3969/j.issn.1006-1959.2020.01.012]
[9]宋国锋.降钙素原检测诊断肺结核合并肺部细菌感染的价值[J].医学信息,2020,33(02):179.[doi:10.3969/j.issn.1006-1959.2020.02.058]
　SONG Guo-feng.Value of Procalcitonin Detection in Diagnosis of Pulmonary Tuberculosis with Pulmonary Bacterial Infection[J].Journal of Medical Information,2020,33(01):179.[doi:10.3969/j.issn.1006-1959.2020.02.058]
[10]丁 媛.PCT及CPR鉴别社区获得性肺炎和肺结核诊断的价值[J].医学信息,2020,33(03):173.[doi:10.3969/j.issn.1006-1959.2020.03.058]
　DING Yuan.Value of PCT and CPR in the Diagnosis of Community-acquired Pneumonia and Tuberculosis[J].Journal of Medical Information,2020,33(01):173.[doi:10.3969/j.issn.1006-1959.2020.03.058]
[11]刘德福.肺结核患者痰中结核分枝杆菌检验的临床价值分析[J].医学信息,2018,31(01):151.[doi:10.3969/j.issn.1006-1959.2018.01.059]
　LIU De-fu.Clinical Value Analysis of Mycobacterium tuberculosis in Sputum of Patients with Pulmonary Tuberculosis[J].Journal of Medical Information,2018,31(01):151.[doi:10.3969/j.issn.1006-1959.2018.01.059]
[12]徐 玥,王 璞.吸烟对肺结核发病、临床特征及转归的影响[J].医学信息,2021,34(05):54.[doi:10.3969/j.issn.1006-1959.2021.05.016]
　XU Yue,WANG Pu.The Effect of Smoking on the Incidence,Clinical Characteristics and Outcome of Tuberculosis[J].Journal of Medical Information,2021,34(01):54.[doi:10.3969/j.issn.1006-1959.2021.05.016]
[13]曾冬梅.血清中结核分枝杆菌IgG、IgM抗体检测在肺结核诊断中的应用价值[J].医学信息,2022,35(22):157.[doi:10.3969/j.issn.1006-1959.2022.22.039]
　ZENG Dong-mei.The Application Value of Serum Mycobacterium Tuberculosis IgG and IgM Antibody Detection in the Diagnosis of Pulmonary Tuberculosis[J].Journal of Medical Information,2022,35(01):157.[doi:10.3969/j.issn.1006-1959.2022.22.039]

更新日期/Last Update: 1900-01-01